EU agency to share results of probe into AstraZeneca shot
LONDON (AP) — The European Union's drug regulator will announce the conclusions of its investigation into the possible connection between AstraZeneca's coronavirus vaccine and rare blood clots later Wednesday, including recommendations that could have far-reaching effects on the use of the shot that is key to global efforts to end the pandemic.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
